Skip to main content

Sung-Hee Kang

Korea University · 医学

研究室紹介

Professor Sung-Hee Kang's research lab focuses on liver diseases, particularly cirrhosis and fatty liver disease, with an emphasis on metabolic and prognostic factors influencing disease progression. The lab investigates sarcopenia as a key predictor of poor outcomes in cirrhotic patients and explores the role of metabolic dysfunction in fatty liver pathogenesis, advocating for the reclassification of NAFLD to MAFLD. Additionally, the lab examines emerging therapies such as rifaximin and mesenchymal stem cell transplantation for managing complications in chronic liver disease.

sarcopeniaMAFLDcirrhosisliver regenerationprognostic factors

Research Overview

Papers
163
Total Citations
2,908
Papers (5y)
47
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
47total
2022
2023
2024
2025
2026
Citations per year (5y)
363total
20222023202420252026

Selected Papers

15
1
Review|361 citations·2017
Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis
Gaeun Kim, Seong Hee Kang, Moon Young Kim, Soon Koo Baik
SJR Q1PLoS ONEOA

Based on this SR and MA, the presence of sarcopenia is related to a poor prognosis and occurrence of cirrhotic complications and could be used for risk assessment. Moreover, Asian participants had higher mortality related to sarcopenia compared to the Western participants.

PhysiologyMedicine
2
Article|261 citations·2021
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Seong Hee Kang, Hye Won Lee, Jeong‐Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon‐Il Choi
SJR Q1Clinical and Molecular HepatologyOA

The committee systematically collected and reviewed the international and domestic literature published in PubMed, MEDLINE, KoreaMed, and other databases. The literature was limited to research papers published in the English and Korean languages. The keywords used were 'nonalcoholic fatty liver disease,' 'nonalcoholic fatty liver,' 'nonalcoholic steatohepatitis,' 'fatty liver,' 'hepatic steatosis,' and 'steatohepatitis.' In addition, keywords related to specific clinical questions were included

EpidemiologyMedicine
3
Article|142 citations·2018
Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score
Seong Hee Kang, Woo Kyoung Jeong, Soon Koo Baik, Seung Hwan, Moon Young Kim
SJR Q1Journal of Cachexia Sarcopenia and MuscleOA

Abstract Background Sarcopenia has been reported as a prognostic factor. We evaluated the impact of sarcopenia to the conventional prognostic factors [Model for End‐Stage Liver Disease (MELD) score, Child–Turcotte–Pugh (CTP) score, hepatic venous pressure gradient (HVPG)] in cirrhosis. Methods Overall, 452 patients with cirrhosis were stratified by MELD score (low < 15, high ≥ 15), CTP class, and HVPG [non‐clinically significant portal hypertension (CSPH), 6–9 mmHg; CSPH, 10–19 mmHg; extremel

HepatologyMedicine
4
Article|94 citations·2017
Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy
Seong Hee Kang, Yun Bin Lee, Jeong‐Hoon Lee, Joon Yeul Nam, Young Woon Chang, Hyeki Cho, Jeong‐Ju Yoo, Young Youn Cho, Eun Ju Cho, Su Jong Yu, M. Y. Kim, Yoon Jun Kim
SJR Q1Alimentary Pharmacology & TherapeuticsOA

BACKGROUND: Rifaximin might decrease the risk of portal hypertension-related complications by controlling small intestinal bacterial overgrowth. AIM: To evaluate whether rifaximin was associated with the risk of death and cirrhotic complications. METHODS: We conducted a retrospective study that included 1042 patients experiencing hepatic encephalopathy (HE): 421 patients without hepatocellular carcinoma (HCC; the non-HCC cohort) and 621 patients with HCC (the HCC cohort). The primary endpoint wa

HepatologyMedicine
5
Review|91 citations·2021
From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Seong Hee Kang, Yuri Cho, Soung Won Jeong, Seung Up Kim, Jin‐Woo Lee, On behalf of Korean NAFLD Study Group
SJR Q1Clinical and Molecular HepatologyOA

There is some dissatisfaction with the term "nonalcoholic fatty liver disease (NAFLD)," which overemphasizes alcohol and underemphasizes the importance of metabolic risk factors in this disease. Recently, a consensus recommended "metabolic (dysfunction)-associated fatty liver disease (MAFLD)" as a more appropriate term to describe fatty liver diseases (FLD) associated with metabolic dysfunction. During the definition change from NAFLD to MAFLD, subjects with FLD and metabolic abnormalities, toge

EpidemiologyMedicine
6
Review|75 citations·2019
Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives
Seong Hee Kang, Moon Young Kim, Young Woo Eom, Soon Koo Baik
SJR Q1Gut and LiverOA

Mesenchymal stem cell transplantation is an emerging therapy for treating chronic liver diseases. The potential of this treatment has been evaluated in preclinical and clinical studies. Although the mechanisms of mesenchymal stem cell transplantation are still not completely understood, accumulating evidence has revealed that their immunomodulation, differentiation, and antifibrotic properties play a crucial role in liver regeneration. The safety and therapeutic effects of mesenchymal stem cells

GeneticsMedicine
7
Article|45 citations·2021
Association between chronic hepatitis B infection and COVID-19 outcomes: A Korean nationwide cohort study
Seong Hee Kang, Dong‐Hyuk Cho, Jimi Choi, Soon Koo Baik, Jun Gyo Gwon, Moon Young Kim
SJR Q1PLoS ONEOA

BACKGROUND/AIMS: We measured the association between underlying chronic hepatitis B (CHB) and antiviral use with infection rates among patients who underwent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing. METHODS: In total, 204,418 patients who were tested for SARS-CoV-2 between January and June 2020 were included. For each case patient (n = 7,723) with a positive SARS-CoV-2 test, random controls (n = 46,231) were selected from the target population who had been exposed to

EpidemiologyMedicine
8
Article|41 citations·2016
Proton Pump Inhibitor Therapy Is Associated With Reduction of Early Bleeding Risk After Prophylactic Endoscopic Variceal Band Ligation
Seong Hee Kang, Hyung Joon Yim, Seung Young Kim, Sang Jun Suh, Jong Jin Hyun, Sung Woo Jung, Young Kul Jung, Ja Seol Koo, Sang Woo Lee
SJR Q3MedicineOA

Endoscopic variceal band ligation (EVL) is an effective procedure to control and prevent variceal bleeding in patients with liver cirrhosis, but it can be complicated by bleeding from post-EVL ulcers. Several studies have reported that proton pump inhibitors (PPIs) decrease the size of post-EVL ulcers. However, evidence are limited as to whether PPIs actually reduce the risk of bleeding after EVL. This study aimed to analyze the factors associated with bleeding after prophylactic EVL and to asse

HepatologyMedicine
9
Article|25 citations·2022
Autoimmune Hepatitis Following Vaccination for SARS-Cov-2 in Korea: Coincidence or Autoimmunity?
Seong Hee Kang, Moon Young Kim, Mee-Yon Cho, Soon Koo Baik
SJR Q2Journal of Korean Medical ScienceOA

Autoimmune hepatitis (AIH) is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells, causing the liver to be inflamed. AIH is one of the manifestations of a coronavirus disease 2019 (COVID-19), as well as an adverse event occurring after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Few cases of AIH have been described after vaccination with two messenger RNA (mRNA)-based vaccines-BTN162b2 (Pfizer-BioNTech) an

HepatologyMedicine
10
Article|24 citations·2018
Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
Seong Hee Kang, Hyeki Cho, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Nam‐Joon Yi, Kwang‐Woong Lee, Kyung‐Suk Suh, Jung‐Hwan Yoon
SJR Q2Journal of Korean Medical ScienceOA

Sorafenib may be beneficial in patients with post-transplant HCC recurrence.

HepatologyMedicine
11
Article|24 citations·2013
Preparation and Patient Evaluation for Safe Gastrointestinal Endoscopy
Seong Hee Kang, Jong Jin Hyun
SJR Q2Clinical EndoscopyOA

Patient evaluation and preparation is the first and mandatory step to ensure safety and quality of endoscopic procedures. This begins and ends with identifying the patient, procedure type, and indication. Every patient has the right to be fully informed about risks and benefits of what is to be performed on them, and the medical personnel should respect the decision made by the patients. Thoroughly performed history taking and physical examination will guide the endoscopists to better stratify r

Pulmonary and Respiratory MedicineMedicine
12
Review|23 citations·2017
Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon
Seong Hee Kang, Moon Young Kim, Soon Koo Baik
SJR Q1Hepatology International
HepatologyMedicine
13
Review|21 citations·2016
Treatment of Severe Alcoholic Hepatitis With Corticosteroid, Pentoxifylline, or Dual Therapy
Young‐Sun Lee, Hyun Jung Kim, Ji Hoon Kim, Yang Jae Yoo, Tae Suk Kim, Seong Hee Kang, Sang Jun Suh, Moon Kyung Joo, Young Kul Jung, Beom Jae Lee, Yeon Seok Seo, Hyung Joon Yim
SJR Q2Journal of Clinical Gastroenterology

BACKGROUND AND AIMS: Although both corticosteroids and pentoxifylline are currently recommended drugs for the treatment of patients with severe alcoholic hepatitis, their effectiveness in reducing mortality remains unclear. In this systematic review, we aimed to evaluate the therapeutic and adverse effects of corticosteroids, pentoxifylline, and combination by using Cochrane methodology and therefore determine optimal treatment for severe alcoholic hepatitis. METHODS: We searched MEDLINE, EMBASE

Pathology and Forensic MedicineMedicine
14
Article|17 citations·2012
Bromocriptine for Control of Hyperthermia in a Patient with Mixed Autonomic Hyperactivity after Neurosurgery: A Case Report
Seong Hee Kang, Min Ja Kim, Il Young Shin, Dae Won Park, Jang Wook Sohn, Young Kyung Yoon
SJR Q2Journal of Korean Medical ScienceOA

Mixed autonomic hyperactivity disorder (MAHD) among patients with acquired brain injury can be rare. A delayed diagnosis of MAHD might exacerbate the clinical outcome and increase healthcare expenses with unnecessary testing. However, MAHD is still an underrecognized and evolving disease entity. A 25-yr-old woman was admitted the clinic due to craniopharyngioma. After an extensive tumor resection, she complained of sustained fever, papillary contraction, hiccup, lacrimation, and sighing. An exte

Critical Care and Intensive Care MedicineMedicine
15
Review|13 citations·2019
Perspectives on Acute Hepatitis A Control in Korea
Seong Hee Kang, Moon Young Kim, Soon Koo Baik
SJR Q2Journal of Korean Medical ScienceOA

Until 1995, the incidence of symptomatic acute hepatitis A was minimal and there were no cases of national outbreak in Korea. However, there was a nationwide outbreak of hepatitis A that peaked in 2009. In 2019, a total of 10,083 cases of acute hepatitis A were reported for seven months of the year according to the Korea Center for Disease Control and Prevention. This may be attributed to the proportion of susceptible subjects in the Korean population, as about 10 years have passed since herd im

HepatologyMedicine

Research Areas

HepatologyEpidemiologyGeneticsOncologyPhysiologyPulmonary and Respiratory Medicine

Sung-Hee Kangの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。